MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more
NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here
VIDEO: MSF's community approach to treating malnutrition in Niger watch it here
WHO's work on the financing of medical research and development is given a fresh start read more
MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
|
 |
|
 |
The Access Campaign is pushing for a TB point-of-care test that can accurately diagnose children and HIV co-infected patients while also working to improve access and treatment for MDR-TB.
Devindra Dercie is 11 years old and lives in Mumbai with his family. Despite many hospital visits, he wasn’t diagnosed with drug-resistant TB until two years after his first symptoms. Like most young children, he had difficulty producing the sputum required for testing and had to be induced with a gastric lavage – essentially a pipe slipped down his throat into his stomach – to extract a sample. He recovered from the diseases after 18 months of treatment.
|
TB continues to be greatly neglected despite its global impact. Children are among the main victims of this neglect and their diagnosis is difficult. Hear from Dr. Marianne Gale, a Medical Advisor with MSF for HIV & TB, as she explains some of the key concerns about diagnosing TB in children. |
|
I want a TB test that works for me! Follow the stories of Devindra, Charity, Rolandi and others describing their difficult journey to being diagnosed with tuberculosis. |
|
What are the minimum requirements for the ideal TB test ? MSF brought together experts from a variety of fields to pool their experience and come up with an agreed list of specifications. Read more |
New Faces of An Old Disease: The spread of TB through populations already infected with HIV and the emergence of drug-resistant strains of the disease are throwing up yet greater medical challenges. Read TB Background Document 
New Drug Trials for Drug-Resistant TB
In a series of papers published by PLoS, international experts explain how innovative trials in patients with drug resistant TB could speed up delivery of new drugs, explore how to fill up the current TB pipeline with additional promising drugs and call for building of clinical trial capacity in developing countries.
Paper on Randomized drug trials
|
Every day about 4,000 people die of TB. When the knowledge is almost there for dramatic improvements in treating TB, why isn't progress being supported? MSF, the International Union Against TB & Lung Disease, and Global Health Advocates/ACTION held a symposium to address this question. Read more |
|
WHA resolution keeps TB in the spotlight "A good step forward" says Access Campaign director Dr. Tido von Schoen-Angerer about the resolution adopted by delegates to the UN health talks. Much more, however, remains to be done. Read on |
|
In Swaziland 80% of patients with TB are also co-infected with HIV/AIDS and TB is the main cause of death for those with HIV/AIDS. To watch this slide show about breaking the silence surrounding HIV/TB co-infection click here |
